Your selections:
- Hussein, Maytham, Schneider-Futschik, Elena K., Velkov, Tony, Paulin, Olivia K. A., Allobawi, Rafah, Crawford, Simon, Zhou, Qi Tony, Hanif, Adil, Baker, Mark, Zhu, Yan, Li, Jian
Polymyxin B combinations with FDA-approved non-antibiotic phenothiazine drugs targeting multi-drug resistance of Gram-negative pathogens
- Hussein, Maytham, Hu, Xiaohan, Paulin, Olivia K. A., Crawford, Simon, Tony Zhou, Qi, Baker, Mark, Schneider-Futschik, Elena K., Zhu, Yan, Li, Jian, Velkov, Tony
- Hussein, Maytham, Karas, John A., Schneider-Futschik, Elena K., Chen, Fan, Swarbrick, James, Paulin, Olivia K. A., Hoyer, Daniel, Baker, Mark, Zhu, Yan, Li, Jian, Velkov, Tony
Contemporary anti-Ebola drug discovery approaches and platforms
- Schneider-Futschik, Elena K., Hoyer, Daniel, Khromykh, Alexander A., Baell, Jonathan B., Marsh, Glenn A., Baker, Mark A., Li, Jian, Velkov, Tony
- Jasim, Raad, Baker, Mark A., Zhu, Yan, Han, Meiling, Schneider-Futschik, Elena K., Hussein, Maytham, Hoyer, Daniel, Li, Jian, Velkov, Tony
Sputum active polymyxin lipopeptides: activity against cystic fibrosis pseudomonas aeruginosa isolates and their interactions with sputum biomolecules
- Schneider-Futschik, Elena K., Paulin, Olivia K. A., Hoyer, Daniel, Roberts, Kade D., Ziogas, James, Baker, Mark A., Karas, John, Li, Jian, Velkov, Tony
Are you sure you would like to clear your session, including search history and login status?